title: [Utility of infliximab in gangrenous pyoderma not associated with inflammatory bowel disease].
authors.forename: I
authors.initials: I
authors.lastname: Pérez-De Pedro
authors.forename: E
authors.initials: E
authors.lastname: Gómez-Moyano
authors.forename: D
authors.initials: D
authors.lastname: López-Carmona
authors.forename: N L
authors.initials: NL
authors.lastname: Muñoz-Roca
authors.forename: E
authors.initials: E
authors.lastname: De Ramón-Garrido
authors.forename: M T
authors.initials: MT
authors.lastname: Camps-García
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D017511:Pyoderma Gangrenosum / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab